ConductScience.org, home

Trial · NCT05616013

Participant flow36

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudyCOMPLETEDBimagrumab 30 mg/kg33
Overall StudyCOMPLETEDPlacebo + Semaglutide 1.0 mg40
Overall StudyCOMPLETEDPlacebo + Semaglutide 2.4 mg48
Overall StudyCOMPLETEDBimagrumab 10 mg/kg + Semaglutide 1.0 mg36
Overall StudyCOMPLETEDBimagrumab 10 mg/kg + Semaglutide 2.4 mg39
Overall StudyCOMPLETEDBimagrumab 30 mg/kg + Semaglutide 1.0 mg43
Overall StudyCOMPLETEDBimagrumab 30 mg/kg + Semaglutide 2.4 mg42
Overall StudyNOT COMPLETEDPlacebo27
Overall StudyNOT COMPLETEDBimagrumab 10 mg/kg29
Overall StudyNOT COMPLETEDBimagrumab 30 mg/kg24
Overall StudyNOT COMPLETEDPlacebo + Semaglutide 1.0 mg16
Overall StudyNOT COMPLETEDPlacebo + Semaglutide 2.4 mg9
Overall StudyNOT COMPLETEDBimagrumab 10 mg/kg + Semaglutide 1.0 mg20
Overall StudyNOT COMPLETEDBimagrumab 10 mg/kg + Semaglutide 2.4 mg17
Overall StudyNOT COMPLETEDBimagrumab 30 mg/kg + Semaglutide 1.0 mg13
Overall StudyNOT COMPLETEDBimagrumab 30 mg/kg + Semaglutide 2.4 mg15

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05616013/flow?page=2